ENANTA PHARMACEUTICALS INC (ENTA) Forecast, Price Target & Analyst Ratings

NASDAQ:ENTA • US29251M1062

Current stock price

12.67 USD
-0.6 (-4.52%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENANTA PHARMACEUTICALS INC (ENTA).

Forecast Snapshot

Consensus Price Target

Price Target
$20.66
+ 63.02% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q2 / 2026
EPS Estimate
-$0.50
Revenue Estimate
17.434M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$20.66
Upside
+ 63.02%
From current price of $12.67 to mean target of $20.66, Based on 14 analyst forecasts
Low
$12.12
Median
$20.40
High
$29.40

Price Target Revisions

1 Month
5.88%
3 Months
6.58%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ENTA. The average price target is 20.66 USD. This implies a price increase of 63.02% is expected in the next year compared to the current price of 12.67.
The average price target has been revised upward by 6.58% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ENTA Current Analyst RatingENTA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ENTA Historical Analyst RatingsENTA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
ENTA was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ENTA.
In the previous month the buy percentage consensus was at a similar level.
ENTA was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2026-01-09HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-14JP MorganInitiate Overweight
2025-09-30WestPark CapitalMaintains Buy -> Buy
2025-09-15Evercore ISI GroupMaintains Outperform -> Outperform
2025-09-02WestPark CapitalInitiate Buy
2025-08-12JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-06-03JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-02-11JMP SecuritiesReiterate Market Outperform -> Market Outperform
2025-02-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-24HC Wainwright & Co.Maintains Buy -> Buy
2024-11-26JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-11-26BairdMaintains Outperform -> Outperform
2024-10-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-09JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-09-27JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-08-06JP MorganMaintains Underweight -> Underweight
2024-08-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-07JMP SecuritiesMaintains Market Outperform -> Market Outperform
2024-05-07HC Wainwright & Co.Maintains Buy -> Buy
2024-02-08JP MorganMaintains Underweight -> Underweight
2023-11-22OppenheimerMaintains Perform -> Perform
2023-11-21JMP SecuritiesMaintains Outperform -> Outperform
2023-11-21HC Wainwright & Co.Maintains Buy -> Buy
2023-10-23HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q2 / 2026
EPS Estimate
-$0.50
Revenue Estimate
17.434M
Revenue Q2Q
16.80%
EPS Q2Q
53.04%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
9.99%
Revenue (3 Months)
9.99%
EPS (1 Month)
20.65%
EPS (3 Months)
34.50%

Next Earnings Summary

ENTA is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.5 USD and the consensus revenue estimate is 17.43M USD.
The next earnings revenue estimate has been revised upward by 9.99% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ENTA revenue by date.ENTA revenue by date.
79.2M
-8.12%		67.635M
-14.60%		65.324M
-3.42%		69.186M
5.91%		65.972M
-4.65%		70.285M
6.54%		89.031M
26.67%		158.15M
77.63%		239.6M
51.50%		304.88M
27.25%		367.91M
20.67%
EBITDA
YoY % growth
ENTA ebitda by date.ENTA ebitda by date.
-134.83M
-11.59%		-119.355M
11.48%		-80.763M
32.33%		-43.86M
45.69%		-63.24M
-44.19%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ENTA ebit by date.ENTA ebit by date.
-137.2M
-10.82%		-121.691M
11.30%		-85.349M
29.86%		-73.674M
13.68%		-85.066M
-15.46%		-88.533M
-4.08%		-67.803M
23.41%		-13.617M
79.92%		119.34M
976.40%		164.22M
37.61%		204M
24.22%
Operating Margin
ENTA operating margin by date.ENTA operating margin by date.
-173.23%-179.92%-130.65%-106.49%-128.94%-125.96%-76.16%-8.61%49.81%53.86%55.45%
EPS
YoY % growth
ENTA eps by date.ENTA eps by date.
-6.37
-7.78%		-5.48
13.97%		-3.83
30.11%		-2.42
36.81%		-2.13
12.17%		-1.96
7.71%		-1.73
11.61%		-0.70
59.41%		1.66
336.23%		2.23
34.36%		2.70
21.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.50
53.04%		-0.54
36.64%		-0.73
15.88%		-0.57
-36.00%		-0.53
-6.56%		-0.47
12.88%		-0.52
28.92%
Revenue
Q2Q % growth		17.434M
16.80%		17.397M
-5.01%		15.657M
3.52%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-12.24M
45.44%		-17.34M
-11.22%		-20.4M
-47.83%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-14.831M
39.53%		-16.238M
14.06%		-20.794M
-13.10%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ENTA Yearly Revenue VS EstimatesENTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
ENTA Yearly EPS VS EstimatesENTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.16%
EPS Next 5 Year
12.68%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1.36%
Revenue Next 5 Year
18.57%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ENANTA PHARMACEUTICALS INC / ENTA Forecast FAQ

Can you provide the average price target for ENANTA PHARMACEUTICALS INC stock?

14 analysts have analysed ENTA and the average price target is 20.66 USD. This implies a price increase of 63.02% is expected in the next year compared to the current price of 12.67.

Can you provide the upcoming earnings date for ENANTA PHARMACEUTICALS INC?

ENANTA PHARMACEUTICALS INC (ENTA) will report earnings on 2026-05-11.

Can you provide the consensus estimates for ENANTA PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of ENANTA PHARMACEUTICALS INC (ENTA) is -0.5 USD and the consensus revenue estimate is 17.43M USD.

What is the consensus rating for ENANTA PHARMACEUTICALS INC (ENTA) stock?

The consensus rating for ENANTA PHARMACEUTICALS INC (ENTA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.